CombinADO研究:评估联合干预策略对HIV青少年及青年病毒抑制、抗逆转录病毒治疗依从性和HIV护理留存影响的整群随机对照试验方案
该整群随机对照试验在莫桑比克楠普拉省12家诊所开展,评估在优化标准护理基础上叠加CombinADO策略对10-24岁接受抗逆转录病毒治疗的HIV青少年及青年病毒抑制(病毒载量<50拷贝/mL)的影响,并监测实施情况。
要点
- CombinADO策略在优化标准护理基础上增加同伴支持、视频、照护者与患者支持组及心理健康筛查转介。
- 主要结局为12个月时病毒载量<50拷贝/mL的HIV青少年及青年比例。
- 次要结局包括自报及TDF水平的抗逆转录病毒治疗依从性和近90天护理参与情况。
核心结论
- CombinADO研究将提供一种新型社区知情多组分干预对改善HIV青少年及青年护理留存、依从性和病毒抑制的有效性证据并指导实施。
- 若发现有效,结果将强化在撒哈拉以南非洲扩大推广的理由。
研究设计与样本
- 整群随机对照试验,在莫桑比克北部楠普拉省12家诊所开展,随机选择6家诊所叠加CombinADO策略。
- 研究条件持续12个月,所有在参与机构寻求护理的10-24岁接受抗逆转录病毒治疗的HIV青少年及青年根据就诊诊所暴露于对照或干预条件。
- 试验结局在HIV青少年及青年、照护者、卫生工作者和关键信息提供者中评估。
- 统计分析按整群随机对照试验的CONSORT指南进行和报告。
- 试验注册于ClinicalTrials.gov NCT04930367,注册日期2021年6月18日。
主要发现
- 主要结局为12个月时参与诊所就诊的HIV青少年及青年中病毒抑制(病毒载量<50拷贝/mL)。
- 次要结局包括抗逆转录病毒治疗依从性(自报和TDF水平)和护理留存(近90天内参与)。
- 将测量CombinADO策略实施期间的 uptake、可行性、可接受性和保真度。
关键数值与推荐
- 对照条件为优化标准护理,包括:(1)广告牌/海报和广播节目,(2)卫生工作者培训,(3)一站式青少年友好服务,(4)信息/激励墙,(5)药盒,(6)卫生工作者临床访视时使用的工具。
- CombinADO策略包括五个附加组分:(1)同伴支持,(2)信息/激励视频,(3)HIV青少年及青年照护者支持组,(4)HIV青少年及青年支持组,(5)心理健康筛查并转介至以青少年为重点的心理健康支持。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adolescents and youth living with HIV (AYAHIV) have worse HIV outcomes than other age groups, particularly in sub-Saharan Africa (SSA). AYAHIV in SSA face formidable health system, interpersonal- and individual-level barriers to retention in HIV care, uptake of ART, and achievement of viral suppression (VS), underscoring an urgent need for multi-component interventions to address these challenges. This cluster-randomized control trial (cRCT) aims to evaluate the effectiveness and monitor implementation of a community-informed multi-component intervention ("CombinADO strategy") addressing individual-, facility-, and community-level factors to improve health outcomes for AYAHIV. METHODS: This trial will be conducted in 12 clinics in Nampula Province, Northern Mozambique. All clinics will implement an optimized standard of care (control) including (1) billboards/posters and radio shows, (2) healthcare worker (HCW) training, (3) one-stop adolescent and youth-friendly services, (4) information/motivation walls, (5) pill containers, and (6) tools to be used by HCW during clinical visits. The CombinADO strategy (intervention) will be superadded to control conditions at 6 randomly selected clinics. It will include five additional components: (1) peer support, (2) informational/motivational video, (3) support groups for AYAHIV caregivers, (4) AYAHIV support groups, and (5) mental health screening and linkage to adolescent-focused mental health support. The study conditions will be in place for 12 months; all AYAHIV (ages 10-24 years, on ART) seeking care in the participating sites will be exposed to either the control or intervention condition based on the clinic they attend. The primary outcome is VS (viral load < 50 copies/mL) at 12 months among AYAHIV attending participating clinics. Secondary outcomes include ART adherence (self-reported and TDF levels) and retention in care (engagement in the preceding 90 days). Uptake, feasibility, acceptability, and fidelity of the CombinADO strategy during implementation will be measured. Trial outcomes will be assessed in AYAHIV, caregivers, healthcare workers, and key informants. Statistical analyses will be conducted and reported in line with CONSORT guidelines for cRCTs. DISCUSSION: The CombinADO study will provide evidence on effectiveness and inform implementation of a novel community-informed multi-component intervention to improve retention, adherence, and VS among AYAHIV. If found effective, results will strengthen the rationale for scale up in SSA. TRIAL REGISTRATION: ClinicalTrials.gov NCT04930367 . Registered on 18 June 2021.
引用
- Mogoba P, Lesosky M, Zerbe A, et al. The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial. Trials. 2021. PMID: 34961567. doi:10.1186/s13063-021-05943-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。